145 related articles for article (PubMed ID: 18665926)
1. An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary.
Mohl A; Marschalek R; Masszi T; Nagy E; Obser T; Oyen F; Sallai K; Bodó I; Schneppenheim R
J Thromb Haemost; 2008 Oct; 6(10):1729-35. PubMed ID: 18665926
[TBL] [Abstract][Full Text] [Related]
2. Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population.
Mohl A; Boda Z; Jager R; Losonczy H; Marosi A; Masszi T; Nagy E; Nemes L; Obser T; Oyen F; Radványi G; Schlammadinger Á; Szélessy ZS; Várkonyi A; Vezendy K; Vilimi B; Schneppenheim R; Bodó I
J Thromb Haemost; 2011 May; 9(5):945-52. PubMed ID: 21362127
[TBL] [Abstract][Full Text] [Related]
3. A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions.
Xie F; Wang X; Cooper DN; Chuzhanova N; Fang Y; Cai X; Wang Z; Wang H
Blood Cells Mol Dis; 2006; 36(3):385-91. PubMed ID: 16690331
[TBL] [Abstract][Full Text] [Related]
4. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.
O'Brien LA; James PD; Othman M; Berber E; Cameron C; Notley CR; Hegadorn CA; Sutherland JJ; Hough C; Rivard GE; O'Shaunessey D; Lillicrap D;
Blood; 2003 Jul; 102(2):549-57. PubMed ID: 12649144
[TBL] [Abstract][Full Text] [Related]
5. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.
Schneppenheim R; Castaman G; Federici AB; Kreuz W; Marschalek R; Oldenburg J; Oyen F; Budde U
J Thromb Haemost; 2007 Apr; 5(4):722-8. PubMed ID: 17371490
[TBL] [Abstract][Full Text] [Related]
6. A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3.
Sutherland MS; Cumming AM; Bowman M; Bolton-Maggs PH; Bowen DJ; Collins PW; Hay CR; Will AM; Keeney S
Blood; 2009 Jul; 114(5):1091-8. PubMed ID: 19372260
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.
Lanke E; Johansson AM; Halldén C; Lethagen S
J Thromb Haemost; 2005 Dec; 3(12):2656-63. PubMed ID: 16359504
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
9. In-frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease.
Bernardi F; Patracchini P; Gemmati D; Pinotti M; Schwienbacher C; Ballerini G; Marchetti G
Hum Mol Genet; 1993 May; 2(5):545-8. PubMed ID: 8518792
[TBL] [Abstract][Full Text] [Related]
10. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
[TBL] [Abstract][Full Text] [Related]
11. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
[TBL] [Abstract][Full Text] [Related]
12. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
14. Allelic frequencies of three VNTRs in intron 40 of the human von Willebrand factor gene in types 1, 2, and 3 von Willebrand disease patients and controls of a Brazilian population.
Mazzini J; Hackel C; Annichino-Bizzacchi JM
Thromb Res; 2000 Dec; 100(6):489-94. PubMed ID: 11152928
[TBL] [Abstract][Full Text] [Related]
15. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
Mancuso DJ; Kroner PA; Christopherson PA; Vokac EA; Gill JC; Montgomery RR
Blood; 1996 Oct; 88(7):2559-68. PubMed ID: 8839848
[TBL] [Abstract][Full Text] [Related]
16. Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene.
Casonato A; Gaucher C; Pontara E; Zucchetto A; Zerbinati P; Mazurier C; Girolami A
Br J Haematol; 1998 Oct; 103(1):39-41. PubMed ID: 9792286
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
18. A 12.3-kb Duplication Within the
Lehner S; Ekhlasi-Hundrieser M; Detering C; Allerkamp H; Pfarrer C; von Depka Prondzinski M
G3 (Bethesda); 2018 Feb; 8(2):577-585. PubMed ID: 29208651
[TBL] [Abstract][Full Text] [Related]
19. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing.
Mohlke KL; Nichols WC; Rehemtulla A; Kaufman RJ; Fagerström HM; Ritvanen KL; Kekomăki R; Ginsburg D
Br J Haematol; 1996 Oct; 95(1):184-91. PubMed ID: 8857958
[TBL] [Abstract][Full Text] [Related]
20. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Goodeve A; Eikenboom J; Castaman G; Rodeghiero F; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Schneppenheim R; Budde U; Ingerslev J; Habart D; Vorlova Z; Holmberg L; Lethagen S; Pasi J; Hill F; Hashemi Soteh M; Baronciani L; Hallden C; Guilliatt A; Lester W; Peake I
Blood; 2007 Jan; 109(1):112-21. PubMed ID: 16985174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
